| Trade Name | KYORIN Pharmaceutical Co.,Ltd. |
|---|---|
| Business | Manufacture and sales of prescription medicines |
| Head Office | 6, Kanda Surugadai 4-Chome, Chiyoda-ku, Tokyo 101-8311 Japan (Access Map) |
| Telephone | 03-3525-4711 |
| Foundation | 1923 |
| Establishment | 1940 |
| Outstanding Shares | 74,268 thousand |
| Common Stock | ¥ 4,317 million |
| Employees | 1,502 (as of March 31, 2020) |
Board of Directors
| Representative Director, Chairman | Minoru Hogawa |
|---|---|
| Representative Director, President and Chief Executive Officer | Shigeru Ogihara |
| Senior Executive Director | Kenji Akutsu |
| Executive Director | Yutaka Ogihara Tomiya Sasahara Michiro Onota Masahide Sugibayashi Koichiro Hagihara Morio Yanagishima |
| Audit & Supervisory Board Member | Tomiharu Matsumoto Shugo Tamaki |
| Senior Corporate Officer | Kei Takahashi Koji Murakami |
| Corporate Officer | Tetsuo Tatsumi Katsuyoshi Fujii Tokutaro Yasue Toshiyuki Tamayama Makoto Yanai Yasuo Nii Kikou Obi Katsuhiro Hamada Takaaki Kaji Noriaki Tamura |
Subsidiaries
ActivX Biosciences, Inc.
| President | Hugh Rosen |
|---|---|
| Capital | US$1 (Percentage of ownership: 100%) |
| Head Office | 11025 N. Torrey Pines Rd. La Jolla, CA 92037, United States |
| Operations | Discovery and evaluation of candidate compounds |
| URL | http://www.activx.com/ |
Kyorin Europe GmbH
| Managing Director | Takashi Kato |
|---|---|
| Capital | €50,000 (Percentage of ownership: 100%) |
| Head Office | Kaiserstrasse 8,60311 Frankfurt am Main, Germany |
| Operations | Research and analysis of other companies' technologies and collection of information concerning clinical trials |